161 related articles for article (PubMed ID: 12824091)
1. Progression of chronic renal failure.
Yu HT
Arch Intern Med; 2003 Jun; 163(12):1417-29. PubMed ID: 12824091
[TBL] [Abstract][Full Text] [Related]
2. Renal protection: progression, regression, remission from nephropathy beyond blood pressure control.
Remuzzi G
Int J Clin Pract Suppl; 2000 May; (110):9-15. PubMed ID: 10912302
[No Abstract] [Full Text] [Related]
3. Progression to renal failure.
Topaloğlu R
Turk J Pediatr; 2005; 47 Suppl():3-8. PubMed ID: 15884660
[TBL] [Abstract][Full Text] [Related]
4. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure, proteinuria and nephropathy in Fabry disease.
Jain G; Warnock DG
Nephron Clin Pract; 2011; 118(1):c43-8. PubMed ID: 21071972
[TBL] [Abstract][Full Text] [Related]
6. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
[TBL] [Abstract][Full Text] [Related]
7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers in the prevention of end stage renal disease: a review.
Derwa A; Peeters P; Vanholder R
Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
[TBL] [Abstract][Full Text] [Related]
9. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of progression of chronic renal damage.
Klahr S
J Nephrol; 1999; 12 Suppl 2():S53-62. PubMed ID: 10688403
[TBL] [Abstract][Full Text] [Related]
11. Glomerular hypertension in the progression of chronic renal failure: role of low protein diet and angiotensin converting enzyme inhibitors.
Cappelli P; Del Rosso G; Di Paolo B; Evangelista M; Albertazzi A
Scand J Urol Nephrol Suppl; 1988; 108():25-30. PubMed ID: 3163827
[No Abstract] [Full Text] [Related]
12. [Mechanism of progression of chronic renal failure and new treatment strategies].
Litwin M
Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
[TBL] [Abstract][Full Text] [Related]
13. Strict blood-pressure control and progression of renal failure in children.
; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
[TBL] [Abstract][Full Text] [Related]
14. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
15. [Renoprotective effects of antihypertensives].
Monhart V
Vnitr Lek; 2004 Jul; 50(7):531-6. PubMed ID: 15323261
[TBL] [Abstract][Full Text] [Related]
16. Toward a unified theory of renal progression.
Harris RC; Neilson EG
Annu Rev Med; 2006; 57():365-80. PubMed ID: 16409155
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
Hollenberg NK; Raij L
Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
[TBL] [Abstract][Full Text] [Related]
18. Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease.
Díaz-Domínguez ME; Fernández-Lucas M; Gomis-Couto A; Ruiz-Roso G; Teruel JL; Quereda C
Nefrologia; 2012 May; 32(3):400-1. PubMed ID: 22592428
[No Abstract] [Full Text] [Related]
19. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.
Wapstra FH; Navis G; de Jong PE; de Zeeuw D
Exp Nephrol; 1996; 4 Suppl 1():47-52. PubMed ID: 9001897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
